Yeleswaram Krishnaswamyinsider trades
In SEC Form 4 filings, Yeleswaram Krishnaswamy is listed as Chief Development Officer of Rapport Therapeutics, Inc. (RAPP). In the last 90 days, Yeleswaram Krishnaswamy sold $2.53M of Rapport Therapeutics, Inc. (RAPP) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RAPPRapport Therapeutics, Inc. | Chief Development Officer | 3 | Aug 26 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-26
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RAPPRapport Therapeutics, Inc. | Aug 25 | Aug 26 | S | 20,799 | $50.31 | Sale −$1,046,421 | 212,063 | Yes | Form 4 |
| RAPPRapport Therapeutics, Inc. | Aug 25 | Aug 26 | S | 16,201 | $51.06 | Sale −$827,184 | 195,862 | Yes | Form 4 |
| RAPPRapport Therapeutics, Inc. | Aug 24 | Aug 26 | S | 13,160 | $50.00 | Sale −$657,978 | 232,862 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.